JOMMI, CLAUDIO

JOMMI, CLAUDIO  

Mostra records
Risultati 1 - 20 di 107 (tempo di esecuzione: 0.056 secondi).
Titolo Data di pubblicazione Autore(i) Rivista Editore
Accordi di managed market entry (risk-sharing): razionale e tendenze evolutive nel SSN 1-gen-2012 Jommi, Claudio PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES -
Analisi di impatto sul budget di WatchmanTM, dispositivo per la prevenzione tromboembolica nei pazienti con fibrillazione atriale 1-gen-2013 Jommi, Claudio; A., Iorio; L., Crippa; A., Gelera; G., Senatore PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES -
Biosimilari 1-gen-2010 Jommi, Claudio PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES -
Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives 1-gen-2018 Rognoni, Carla; Bertolani, Arianna; Jommi, Claudio GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT -
CAR T-cell therapies in Italy: patient access barriers and recommendations for health system solutions 1-gen-2022 Jommi, Claudio; Bramanti, Stefania; Pani, Marcello; Ghirardini, Alessandro; Santoro, Armando FRONTIERS IN PHARMACOLOGY -
Clinical management of chronic Kidney disease patients in Italy: results from the IRIDE study 1-gen-2018 Cozzolino, Mario; Bolasco, Piergiorgio; Ronco, Claudio; Conte, Giuseppe; Menè, Paolo; Cristina Mereu, Maria; Di Luca, Marina; Roccatello, Dario; Rosati, Alberto; Jommi, Claudio; Maria Costanzo, Anna; Gualberti, Giuliana; di Luzio Paparatti, Umberto; Remuzzi, Giuseppe NEPHRON JOURNALS -
Il confronto internazionale tra prezzi dei farmaci: aspetti metodologici, principali risultati in letteratura e studio sui farmaci con obbligo di prescrizione 1-gen-2008 Jommi, Claudio; Aguzzi, Giovanni; Otto, MONICA HILDEGARD - Il Sole 24 Ore
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study 1-gen-2018 Jommi, Claudio; Armeni, Patrizio; Battista, Margherita; di Procolo, Paolo; Conte, Giuseppe; Ronco, Claudio; Cozzolino, Mario; Costanzo, Anna Maria; di Luzio Paparatti, Umberto; Concas, Gabriella; Remuzzi, Giuseppe PHARMACOECONOMICS-OPEN -
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service 1-gen-2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Grossi, Francesco; Costa, Francesco CLINICAL THERAPEUTICS -
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service 1-gen-2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Colombo, Nicoletta; Costa, Francesco CLINICAL THERAPEUTICS -
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system 1-gen-2021 Riva, Silvia; Arenare, Laura; Di Maio, Massimo; Efficace, Fabio; Montesarchio, Vincenzo; Frontini, Luciano; Giannarelli, Diana; Bryce, Jane; Del Campo, Laura; De Lorenzo, Francesco; Iannelli, Elisabetta; Traclò, Francesca; Gitto, Lara; Jommi, Claudio; Vaccaro, Concetta Maria; Barberio, Daniela; Cinieri, Saverio; Porta, Camillo; Del Mastro, Lucia; Zagonel, Vittorina; Aligi Cogoni, Alessio; Bordonaro, Roberto; Gimigliano, Anna; Piccirillo, Maria Carmela; Guizzaro, Lorenzo; Gallo, Ciro; Perrone, Francesco BMJ OPEN -
Current pipelines for neglected diseases 1-gen-2014 P., Procolo; Jommi, Claudio PLOS ONE -
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency 1-gen-2019 Villa, Federico; Tutone, Michaela; Altamura, Gianluca; Antignani, Sara; Cangini, Agnese; Fortino, Ida; Melazzini, Mario; Trotta, Francesco; Tafuri, Giovanni; Jommi, Claudio HEALTH POLICY -
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol 1-gen-2019 Riva, Silvia; Bryce, Jane; De Lorenzo, Francesco; Del Campo, Laura; Di Maio, Massimo; Efficace, Fabio; Frontini, Luciano; Giannarelli, Diana; Gitto, Lara; Iannelli, Elisabetta; Jommi, Claudio; Montesarchio, Vincenzo; Traclò, Francesca; Vaccaro, Concetta Maria; Gallo, Ciro; Perrone, Francesco BMJ OPEN -
Diagnostic accuracy of HLA-B*5701 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review 1-gen-2014 S., Cargnin; Jommi, Claudio; Canonico, P. L. PHARMACOGENOMICS -
The economic impact of a switch from prescription-only to non-prescription drugs in Italy 1-gen-2018 Otto, Monica Hildegard; Pillarella, Carla; Jommi, Claudio FRONTIERS IN PHARMACOLOGY -
The economic impact of compassionate use of medicines 1-gen-2021 Jommi, Claudio; Pantellini, Federico; Stagi, Lisa; Verykiou, Maria; Cavazza, Marianna BMC HEALTH SERVICES RESEARCH -
Education and research on drug market access in low-income countries: the experience of the Department of Pharmaceutical Sciences in Novara 1-gen-2013 Jommi, Claudio; P., di Procolo; V., Drago - EGEA
The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service 1-gen-2020 Jommi, Claudio; Cipriani, Filippo; Fanelli, Francesca; Pedone, Maria Paola; Canonica, Walter GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT -
EQ-5D-5L population norms for Italy In corso di stampa Meregaglia, Michela; Malandrini, Francesco; Finch, Aureliano Paolo; Ciani, Oriana; Jommi, Claudio APPLIED HEALTH ECONOMICS AND HEALTH POLICY -